# OnCo record tiger-trial (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/tiger-trial/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "tiger-trial", "NCT02375204" ;
  schema:name "TIGER: standard-dose TIP versus high-dose TI-CE with stem cell transplant as first salvage for relapsed germ cell tumours"@en ;
  schema:description "The trial meant to settle a thirty-year argument: whether men whose germ cell tumour comes back after cisplatin should get standard salvage chemotherapy or high-dose chemotherapy with a stem cell transplant."@en ;
  schema:url <https://onco.cc/trials/tiger-trial/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT02375204> ;
  onco:status "active" ;
  onco:tag "owner-request" ;
  onco:phase "3" ;
  schema:startDate "2015-08-06" ;
  onco:cancers <https://onco.cc/cancers/testicular/>, <https://onco.cc/cancers/extragonadal-germ-cell-tumour/>, <https://onco.cc/cancers/non-seminoma/> ;
  onco:technologies <https://onco.cc/technologies/autologous-stem-cell-transplant/> ;
  onco:drugs <https://onco.cc/drugs/paclitaxel/>, <https://onco.cc/drugs/ifosfamide/>, <https://onco.cc/drugs/cisplatin/>, <https://onco.cc/drugs/carboplatin/>, <https://onco.cc/drugs/etoposide/> ;
  onco:companies <https://onco.cc/companies/alliance-oncology/> .
